Vitamins, Nutritional Supplements and Over The Counter Medicines
Injury Type
Monetary Loss
Investigation Details
This is an investigation and a pending class action against Bayer Healthcare for potentially illegally marketing two unapproved drugs, "Bayer Aspirin with Heart Advantage" and "Bayer Women's Low Dose Aspirin + Calcium".
Both of the drugs are currently sold over-the-counter and according to the Food and Drug Administration require an approved new drug application to be considered for legal marketing. The drugs both contain aspirin with either phytosterols or calcium in addition to being labeled as pain relievers. Both drugs promote use of the pills to reduce the risks of heart disease while the women's low dose aspirin also claims to fight osteoporosis.
Currently the two drugs are only FDA approved for pain treatment, according to reports. Reports indicate these drugs require a health care professional's diagnosis and supervision, meaning these products can't be labeled for use by consumers and the FDA bans such drugs from over-the-counter sales altogether.
If you've ever purchased either of the drugs, we'd like to hear from you.
Defendant Details
Name (Stock Symbol)
Brief Description
Bayer AG
Bayer AG manufactures pharmaceuticals and consumer products.